Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2009

01-03-2009 | Article

Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine

Authors: M. Riffelmann, M. Littmann, C. Hülße, C. H. Wirsing von König

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2009

Login to get access

Abstract

Antibody decay after a single dose of acellular pertussis vaccine containing 25 μg of pertussis toxin (PT), 25 μg of filamentous hemagglutin (FHA), and traces of pertactin (PRN) was monitored in health-care workers. Blood was sampled 4 weeks (n = 246), 1 year (n = 187), 2 years (n = 53), 3 years (n = 134), and 4 years (n = 37) after vaccination. IgG anti-PT, IgG anti-FHA and IgG anti-PRN were measured by ELISA. Peak median antibodies to PT, FHA, and PRN were 314, 785, and 84 EU/ml respectively. IgG anti-PT decreased to a median of 29% (76 EU/ml), 18% (64 EU/ml), 19% (58 EU/ml), and 20% (63 EU/ml) of the peak value after 1, 2, 3, and 4 years respectively. IgG anti-FHA decreased more slowly, but showed similar decay patterns. In German health-care workers antibodies to pertussis antigens decayed rapidly within the first year after vaccination, but remained stable after 2, 3, and 4 years. This observation may have implications for the timing of booster vaccinations in adults.
Literature
1.
2.
go back to reference STIKO (2000) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut. Version 2000 Epidemiol Bull 2:9–20 STIKO (2000) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut. Version 2000 Epidemiol Bull 2:9–20
3.
go back to reference Kretsinger K, Broder KR, Cortese MM et al (2006) Preventing tetanus, diphtheria, and pertussis in adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendations of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC) for use of Tdap among health-care personnel. MMWR Recomm Rep 55:1–37 Kretsinger K, Broder KR, Cortese MM et al (2006) Preventing tetanus, diphtheria, and pertussis in adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendations of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC) for use of Tdap among health-care personnel. MMWR Recomm Rep 55:1–37
4.
go back to reference Sandora TJ, Gidengil CA, Lee GM (2008) Pertussis vaccination for health care workers. Clin Microbiol Rev 21:426–434PubMedCrossRef Sandora TJ, Gidengil CA, Lee GM (2008) Pertussis vaccination for health care workers. Clin Microbiol Rev 21:426–434PubMedCrossRef
5.
go back to reference Christie CDC, Garisson KM, Kiely L, Gupta RK, Heubi J, Marchant CD (2001) A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993. Clin Infect Dis 33:997–1003PubMedCrossRef Christie CDC, Garisson KM, Kiely L, Gupta RK, Heubi J, Marchant CD (2001) A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993. Clin Infect Dis 33:997–1003PubMedCrossRef
7.
go back to reference Herden P, Bier N, Schneeweiss B, Palitsch D, Wirsing von Koenig CH (2000) Interchangeability of acellular pertussis vaccines during primary immunization. Pediatr Infect Dis J 19:757–759PubMed Herden P, Bier N, Schneeweiss B, Palitsch D, Wirsing von Koenig CH (2000) Interchangeability of acellular pertussis vaccines during primary immunization. Pediatr Infect Dis J 19:757–759PubMed
8.
go back to reference Swidsinski S, Schlesinger FL, Mebel S (1989) Keuchhusten: nicht augerottet aber vergessen. Z Arzt Fortbild (Jena) 83:309–312 Swidsinski S, Schlesinger FL, Mebel S (1989) Keuchhusten: nicht augerottet aber vergessen. Z Arzt Fortbild (Jena) 83:309–312
9.
go back to reference Wirsing von König CH, Gounis D, Schmitt HJ, Laukamp S, Bogaerts H (1999) Single sample serological diagnosis of pertussis. Eur J Clin Microbiol Infect Dis 18:341–345PubMedCrossRef Wirsing von König CH, Gounis D, Schmitt HJ, Laukamp S, Bogaerts H (1999) Single sample serological diagnosis of pertussis. Eur J Clin Microbiol Infect Dis 18:341–345PubMedCrossRef
10.
go back to reference Wirsing von Koenig CH, Schmitt HJ (1996) Epidemiological aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine. J Infect Dis 174:S281–S286 Wirsing von Koenig CH, Schmitt HJ (1996) Epidemiological aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine. J Infect Dis 174:S281–S286
11.
go back to reference Le T, Cherry JD, Chang SJ et al (2004) Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 190:535–544PubMedCrossRef Le T, Cherry JD, Chang SJ et al (2004) Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 190:535–544PubMedCrossRef
12.
go back to reference McIntyre P, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM (2004) High levels of antibody in adults three years after vaccination with a reduced content diphtheria-tetanus-acellular pertussis vaccine. Vaccine 23:380–385PubMedCrossRef McIntyre P, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM (2004) High levels of antibody in adults three years after vaccination with a reduced content diphtheria-tetanus-acellular pertussis vaccine. Vaccine 23:380–385PubMedCrossRef
13.
go back to reference Edelman KJ, He Q, Makinen JP, Haanpera MS, Tran Minh NN, Schuerman L et al (2004) Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. Clin Infect Dis 39:179–185PubMedCrossRef Edelman KJ, He Q, Makinen JP, Haanpera MS, Tran Minh NN, Schuerman L et al (2004) Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. Clin Infect Dis 39:179–185PubMedCrossRef
14.
go back to reference Edelman K, He Q, Mäkinen J et al (2007) Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 44:1271–1277PubMedCrossRef Edelman K, He Q, Mäkinen J et al (2007) Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 44:1271–1277PubMedCrossRef
15.
go back to reference Barreto L, Guasparini R, Meekison W, Noya F, Young L, Mills E (2007) Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 25:8172–8179PubMedCrossRef Barreto L, Guasparini R, Meekison W, Noya F, Young L, Mills E (2007) Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 25:8172–8179PubMedCrossRef
16.
Metadata
Title
Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine
Authors
M. Riffelmann
M. Littmann
C. Hülße
C. H. Wirsing von König
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0625-0

Other articles of this Issue 3/2009

European Journal of Clinical Microbiology & Infectious Diseases 3/2009 Go to the issue